These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19246949)

  • 1. Systemic therapy of metastatic breast cancer: the truth beyond the clinical trials.
    Gueth U; Huang DJ; Schoetzau A; Holzgreve W; Wight E
    Oncology; 2009; 76(4):247-53. PubMed ID: 19246949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fifteen-year trends in metastatic breast cancer survival in Greece.
    Dafni U; Grimani I; Xyrafas A; Eleftheraki AG; Fountzilas G
    Breast Cancer Res Treat; 2010 Feb; 119(3):621-31. PubMed ID: 19915976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
    Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC
    BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine therapy in metastatic breast cancer: data from Breast Cancer Registry of Palermo, 1999-2005 .
    Amodio R; Zarcone M; Agostara B; Staiti R; Granata OM; Carruba G; Traina A
    Ann N Y Acad Sci; 2009 Feb; 1155():227-31. PubMed ID: 19250208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy.
    Liu GF; Yang Q; Haffty BG; Moran MS
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1304-8. PubMed ID: 19386432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity.
    Vetter M; Huang DJ; Bosshard G; Güth U
    Acta Oncol; 2013 Jan; 52(1):57-65. PubMed ID: 23083423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival of patients with metastatic breast cancer in routine care: results of a retrospective study in a community-based oncology group practice 1995-2005.
    Weide R; Mergenthaler U; Pandorf A; Arndt H; Heymanns J; Thomalla J; Köppler H
    Onkologie; 2009 Mar; 32(3):107-13. PubMed ID: 19295249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
    Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of current palliative treatment on the survival of patients with breast cancer.
    Devitt JE; Advent DA
    Can J Surg; 1977 Jan; 20(1):46-50. PubMed ID: 64291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
    Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
    Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy.
    Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA
    J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
    Abouassaly R; Paciorek A; Ryan CJ; Carroll PR; Klein EA
    Cancer; 2009 Oct; 115(19):4470-6. PubMed ID: 19637339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance treatment in metastatic breast cancer.
    Sánchez-Muñoz A; Pérez-Ruiz E; Ribelles N; Márquez A; Alba E
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
    Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
    Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliation in patients with metastatic breast cancer often better with antitumour treatment than with only symptomatic treatment].
    Soetekouw PM; van Dongen R; Maas R; Bult P; Boetes C; Tjan-Heijnen VC
    Ned Tijdschr Geneeskd; 2007 Mar; 151(12):673-8. PubMed ID: 17447590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chemotherapy in women with metastatic breast cancer diagnosed 1990-2003.
    Anderson DM; Rolnick SJ; Jackson J; Amundson J; Asche SE; Loes LM
    Clin Breast Cancer; 2007 Oct; 7(10):801-3. PubMed ID: 18021483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study.
    Ruhstaller T; von Moos R; Rufibach K; Ribi K; Glaus A; Spaeti B; Koeberle D; Mueller U; Hoefliger M; Hess D; Boehme C; Thuerlimann B
    Oncology; 2009; 76(2):142-8. PubMed ID: 19158446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.
    Sorbye H; Pfeiffer P; Cavalli-Björkman N; Qvortrup C; Holsen MH; Wentzel-Larsen T; Glimelius B
    Cancer; 2009 Oct; 115(20):4679-87. PubMed ID: 19562777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
    Trudeau ME; Clemons MJ; Provencher L; Panasci L; Yelle L; Rayson D; Latreille J; Vandenberg T; Goel R; Zibdawi L; Rahim Y; Pouliot JF
    J Clin Oncol; 2009 Dec; 27(35):5906-10. PubMed ID: 19858391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.